Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer.
Alan CelikTobias BergMaj-Britt JensenErik JakobsenHanne Melgaard NielsenIben KümlerVesna GlavicicJeanette Dupont JensenAnn KnoopPublished in: Breast cancer : basic and clinical research (2023)
The study was registered and approved by the Danish Capital Regions research overview (P-2021-605).
Keyphrases